GARDskin approved by OECD
THE FIRST AND ONLY Genomics and Machine-learning based in vitro skin sensitization assay
The GARD® technology: An holistic approach
SenzaGen provides state-of-the-art non-animal tests for assessing a substance’s allergenicity. With excellent predictivity, the tests meet needs in several industries and help companies develop, produce and deliver safer, ethical and more sustainable products.
Press Releases
21 Jun, 2022
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
10 May, 2022
News
IR
English
Corporate Information
Sales
Order
05 May, 2022
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
News Posts
Quick Links
Contact
Privacy Policy (En)
Privacy Policy (Sv)
General Terms and Conditions
© SenzaGen 2026





